Načítá se...
Blood Biomarkers of Uveal Melanoma: Current Perspectives
The detection of metastases in patients with a diagnosis of uveal melanoma (UM) is a controversial issue. While only 1% of the patients have detectable metastases at the time of diagnosis, up to 30% of them will develop liver metastases within 5 years of treatment. UM spreads hematogenously, therefo...
Uloženo v:
| Vydáno v: | Clin Ophthalmol |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6980862/ https://ncbi.nlm.nih.gov/pubmed/32021081 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S199064 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|